PH receives 1.4 million more ADB loan-procured COVID vaccine doses | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

PH receives 1.4 million more ADB loan-procured COVID vaccine doses

By: - Reporter /
/ 12:45 PM December 24, 2021

FILE Arrival of government procured COVID-19 vaccines. Image from NTF Against COVID-19 / Facebook

FILE Arrival of government procured COVID-19 vaccines. Image from NTF Against COVID-19 / Facebook

MANILA, Philippines — The Philippines received its procurement of some 1.4 million additional Pfizer COVID-19 vaccine doses early Friday.

The government purchased the 1,405,170 doses through a loan from the Asian Development Bank, the National Task Force Against COVID-19 said.

Article continues after this advertisement

The aircraft that transported the anti-COVID shots landed at the Ninoy Aquino International Airport Terminal 1.

FEATURED STORIES

On Thursday, 2,730,780 Pfizer vaccine doses, also bought by the government, were delivered in the country.

Of the around 192 million various COVID-19 vaccines that have arrived in the country since February, 104 million have already been injected.

Article continues after this advertisement

Around 46.3 million individuals in the country are fully vaccinated against COVID-19 as of December 22.

The government is targeting to fully immunize 54 million people by year end to achieve population protection.

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

MOST READ
www
technology
globalnation
business
business
business
TAGS: government loans, Pfizer

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.